NCT04307290View on ClinicalTrials.gov

Dexmedetomidine on Tourniquet Induced -Systemic Effects

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 3, 2020

Primary Completion Date

February 10, 2020

Study Completion Date

March 5, 2020

Conditions
Arthropathy of KneeSpinal AnesthesiaTourniquetIschemia-reperfusion Injury
Interventions
DRUG

Dexmedetomidine Hydrochloride, or Saline

drug infusion from 10 min before the start of surgery to the end of surgery

Trial Locations (1)

570-711

WonwangUH, Iksan

All Listed Sponsors
lead

Wonkwang University Hospital

OTHER

NCT04307290 - Dexmedetomidine on Tourniquet Induced -Systemic Effects | Biotech Hunter | Biotech Hunter